Abstract
Post-acute neurological sequelae of COVID-19 affect millions of people worldwide, yet little data is available to guide treatment strategies for the most common symptoms. We conducted a scoping review of PubMed/Medline from 1/1/2020–4/1/2023 to identify studies addressing diagnosis and treatment of the most common post-acute neurological sequelae of COVID-19 including: cognitive impairment, sleep disorders, headache, dizziness/lightheadedness, fatigue, weakness, numbness/pain, anxiety, depression and post-traumatic stress disorder. Utilizing the available literature and international disease-specific society guidelines, we constructed symptom-based differential diagnoses, evaluation and management paradigms. This pragmatic, evidence-based consensus document may serve as a guide for a holistic approach to post-COVID neurological care and will complement future clinical trials by outlining best practices in the evaluation and treatment of post-acute neurological signs/symptoms.
Original language | English (US) |
---|---|
Article number | 120827 |
Journal | Journal of the Neurological Sciences |
Volume | 454 |
DOIs | |
State | Published - Nov 15 2023 |
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. JAF reports funding from NIH/NINDS , NIH/NHLBI , NIH/NIA and NIH/NCATS for COVID-19 related research. ASW reports funding by the School of Medicine, Technical University of Munich , Grant Number H.40001.1.7-08 in support of the Global COVID-19 Neuro Research Coalition. We acknowledge the contributions of Erica Westenberg to the coordination of the Global COVID-19 Neuro Research Coalition and the management of the current manuscript.
Keywords
- COVID-19
- Diagnosis
- Evaluation
- Management
- Neurologic
- SARS-COV-2
- Therapeutics
- Therapy
- Treatment
ASJC Scopus subject areas
- Neurology
- Clinical Neurology